Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 48, 4620-4628, August 15, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woodworth, C. D.
Right arrow Articles by DiPaolo, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woodworth, C. D.
Right arrow Articles by DiPaolo, J. A.

Characterization of Normal Human Exocervical Epithelial Cells Immortalized in Vitro by Papillomavirus Types 16 and 18 DNA1

C. D. Woodworth2, P. E. Bowden, J. Doniger, L. Pirisi3, W. Barnes, W. D. Lancaster and J. A. DiPaolo

Laboratory of Biology, Division of Cancer Etiology, National Cancer Institute, Bethesda, Maryland 20892 [C. D. W., P. E. B., J. D., L. P., J. A. D.], and Department of Obstetrics and Gynecology, Georgetown University Medical Center, Washington, DC 20007 [W. B., W. D. L.]

An in vitro system for studying the interaction between human papillomavirus (HPV) 16 and 18 recombinant DNA and normal human exocervical epithelial cells is described. Eight HPV-immortalized human exocervical epithelial cell lines were established; all the lines contained either integrated HPV16 or 18 sequences and expressed HPV mRNAs. Thus, integration and expression appear to be required for immortalization. Immortalized cells (>200 population doublings to date) divided rapidly (doubling time of 30 to 46 h) and morphologically resembled primary cultures of normal human exocervical epithelial cells. They expressed a keratin pattern consistent with their origin from exocervical epithelium. When cultured at high density or in the presence of serum they terminally differentiated. Sublines resistant to terminal differentiation were selected by growth in serum-supplemented medium. Keratin pattern changes suggest they have some properties in common with cervical squamous carcinoma cells. However, HPV-immortalized cell lines were not tumorgenic in nude mice. Thus, HPV16/18 is not carcinogenic by itself. These cell lines represent an appropriate model for studying factors that regulate HPV gene expression in normal cervical epithelial cells and examining the influence of cocarcinogens on neoplastic progression.

1 The investigation was supported in part by Grant CA32638 awarded to W. D. L. by the National Cancer Institute, Department of Health and Human Services, Bethesda, MD 20892.

2 To whom requests for reprints should be addressed, at the National Cancer Institute, Laboratory of Biology, Division of Cancer Etiology, Building 37, Room 2A19, Bethesda, MD 20892.

3 Present address: Department of Chemistry, University of South Carolina, Columbia, SC 29208.

Received 12/16/87. Revised 4/12/88. Revised 5/13/88. Accepted 5/19/88.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
C. D. Woodworth, E. Michael, D. Marker, S. Allen, L. Smith, and M. Nees
Inhibition of the epidermal growth factor receptor increases expression of genes that stimulate inflammation, apoptosis, and cell attachment
Mol. Cancer Ther., April 1, 2005; 4(4): 650 - 658.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H. E. van Gijssel, R. L. Divi, O. A. Olivero, M. J. Roth, G.-Q. Wang, S. M. Dawsey, P. S. Albert, Y.-L. Qiao, P. R. Taylor, Z.-W. Dong, et al.
Semiquantitation of Polycyclic Aromatic Hydrocarbon-DNA Adducts in Human Esophagus by Immunohistochemistry and the Automated Cellular Imaging System
Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1622 - 1629.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Nees, J. M. Geoghegan, T. Hyman, S. Frank, L. Miller, and C. D. Woodworth
Papillomavirus Type 16 Oncogenes Downregulate Expression of Interferon-Responsive Genes and Upregulate Proliferation-Associated and NF-{kappa}B-Responsive Genes in Cervical Keratinocytes
J. Virol., May 1, 2001; 75(9): 4283 - 4296.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
G. S. Akerman, W. H. Tolleson, K. L. Brown, L. L. Zyzak, E. Mourateva, T. S. W. Engin, A. Basaraba, A. L. Coker, K. E. Creek, and L. Pirisi
Human Papillomavirus Type 16 E6 and E7 Cooperate to Increase Epidermal Growth Factor Receptor (EGFR) mRNA Levels, Overcoming Mechanisms by which Excessive EGFR Signaling Shortens the Life Span of Normal Human Keratinocytes
Cancer Res., May 1, 2001; 61(9): 3837 - 3843.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. C. Goodwin, E. Yang, C.-J. Lee, H.-W. Lee, D. DiMaio, and E.-S. Hwang
Rapid induction of senescence in human cervical carcinoma cells
PNAS, September 26, 2000; 97(20): 10978 - 10983.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Nees, J. M. Geoghegan, P. Munson, V. Prabhu, Y. Liu, E. Androphy, and C. D. Woodworth
Human Papillomavirus Type 16 E6 and E7 Proteins Inhibit Differentiation-dependent Expression of Transforming Growth Factor-{beta}2 in Cervical Keratinocytes
Cancer Res., August 1, 2000; 60(15): 4289 - 4298.
[Abstract] [Full Text]


Home page
J. Virol.Home page
D. A. Francis, S. I. Schmid, and P. M. Howley
Repression of the Integrated Papillomavirus E6/E7 Promoter Is Required for Growth Suppression of Cervical Cancer Cells
J. Virol., March 15, 2000; 74(6): 2679 - 2686.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Ben-Bassat, S. Rosenbaum-Mitrani, Z. Hartzstark, R. Levitzki, M. Chaouat, Z. Shlomai, B. Y. Klein, N. Kleinberger-Doron, A. Gazit, R. Tsvieli, et al.
Tyrphostins That Suppress the Growth of Human Papilloma Virus 16-Immortalized Human Keratinocytes
J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1442 - 1457.
[Abstract] [Full Text]


Home page
J. Virol.Home page
S. Song, H. C. Pitot, and P. F. Lambert
The Human Papillomavirus Type 16 E6 Gene Alone Is Sufficient To Induce Carcinomas in Transgenic Animals
J. Virol., July 1, 1999; 73(7): 5887 - 5893.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1988 by the American Association for Cancer Research.